DexCom Inc (DXCM)

DXCM (NASDAQ:Health Services) EQUITY
$64.45
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | DXCM Avg Daily Volume: 1,194,100
Last Update: 12/05/16 - 4:00 PM EST
Volume: 0
YTD Performance: -22.01%
Open: $0.00
Previous Close: $64.45
52 Week Range: $47.92 - $96.38
Oustanding Shares: 84,524,171
Market Cap: 5,398,558,802
6-Month Chart
TheStreet Ratings Grade for DXCM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 8
Moderate Buy 1 2 2 2
Hold 3 3 4 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.73 1.72 1.84 1.73
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -95.33
Price Earnings Comparisons:
DXCM Sector Avg. S&P 500
-95.33 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-30.64% -25.25% 87.69%
GROWTH 12 Mo 3 Yr CAGR
Revenue 55.10 3.00 0.58
Net Income 0.00 0.10 0.00
EPS 0.00 -0.10 0.00
Earnings for DXCM:
EBITDA -0.05B
Revenue 0.40B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $-0.07 $-0.14 $-0.77 $-0.03
Number of Analysts 12 9 12 13
High Estimate $0.08 $0.00 $-0.62 $0.64
Low Estimate $-0.16 $-0.26 $-0.86 $-0.42
Prior Year $0.02 $-0.23 $-0.26 $-0.77
Growth Rate (Year over Year) -470.83% 39.13% -195.51% 95.80%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Bullish
Oct 31, 2016 | 8:13 AM EDT
DXCM was upgraded from Neutral to Buy, BTIG said. $92 price target. Stock has pulled back to an attractive level and fundamentals have ...
But several airline and retail stocks are proving highly volatile.
Results on conference picks are split as hedge fund industry contends with criticism.
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.
A combination of price and range compression often precedes volatility squeeze breakouts.
Bullish
Oct 15, 2015 | 7:20 AM EDT
DXCM was upgraded to Outperform, Leerink Partners said. $100 price target. Stock is down sharply, but fundamentals are as strong as eve...

Apple Stock Is Still Cheap Real Money Pro($)

Even at a record valuation, the shares seem poised to move higher.
Bearish
Jan 06, 2015 | 7:15 AM EST
DXCM was downgraded from Buy to Neutral, Sterne Agee said. Valuation call, as the stock surpassed the previous $56 price target. 
You should be watching how DexCom is trading.
Bullish
Apr 10, 2014 | 8:04 AM EDT
DXCM was upgraded from Neutral to Buy, Sterne Agee said. $50 price target. Superior CGM technology will continue to drive strong revenu...

Columnist Conversations

BC is moving well today.  Shares are up over 3.5% on fairly heavy trade and are trading at new 2016 highs...
Markets taking the latest rejection of the status quo in Italy in stride as the reforms were expected to lose ...
Merck continues to retreat from November's failed breakout.  Back on 9th and 10th of last month the stock...
Trifecta Stocks name Disney is bumping up to the 100 area hereon some good turnover and bullish flow today (an...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.